Double-Blind, Randomised, Placebo-Controlled Study Comparing the Efficacy and Safety of Two Fixed Dosages of a Novel Antidepressant Compound to That of Placebo in Patients With Major Depressive Disorder.

Trial Profile

Double-Blind, Randomised, Placebo-Controlled Study Comparing the Efficacy and Safety of Two Fixed Dosages of a Novel Antidepressant Compound to That of Placebo in Patients With Major Depressive Disorder.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Feb 2017

At a glance

  • Drugs Vortioxetine (Primary) ; Venlafaxine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Lundbeck A/S
  • Most Recent Events

    • 18 Jul 2011 Results published in the International Journal of Neuropsychopharmacology.
    • 11 Sep 2009 Results were presented at the 22nd Annual Congress of the European College of Neuropsychopharmacology.
    • 19 May 2009 Results presented at the 162nd Annual Meeting of the American Psychiatric Association (APA 2009).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top